Burning Rock Biotech Limited (BNR) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Burning Rock Biotech Limited (BNR) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $14.0M, listed on NASDAQ, employing roughly 667 people, carrying a beta of 1.29 to the broader market. Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the People's Republic of China. Led by Yusheng Han, public since 2020-06-12.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for BNR as of 2026-11-22; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →